| Protocol ID | NCT04213989 |
| Registration Date | 2019-12-30 |
| Status | completed |
| Sponsor | Thomas Wright, MD |
| Country | United States |
| Industry | industry |
| Blinding | unblinded |
| Center Type | singel-center RCT |
| Scope | national RCT |
| First Patient In | 2020-01-31 |
| Last Patient Out | 2021-11-24 |
| Publication | y |
| Gender % | FEMALE |
| Mean Age | 18 Years - 70 Years |
NCT04213989
An Investigator-initiated Study Assessing the Effect of Intermittent Pneumatic Compression (IPC) on Symptoms and Quality of Life in Women With Lipo-lymphedema (Lipedema With Swelling)
| Field |
GLM
glm-5.1 9262ms / 9689 tok |
CLAUDE
claude-sonnet-4-20250514 4659ms / 11023 tok |
OPENAI
gpt-4o 3248ms / 9522 tok |
Review |
|---|---|---|---|---|
| rct_type | parallel RCT | parallel RCT | parallel RCT | OK |
| cancer_status | non-cancer | non-cancer | non-cancer | OK |
| non_cancer_spec | N/A | N/A | N/A | OK |
| setting_patient | outpatient | outpatient | outpatient | OK |
| setting_place |
home care
home care → home care
shaky reasoning✓ Unanimous
Initial: home care
Requery: home care — The intervention involves an in-home advanced pneumatic compression device used daily for 1 hour to provide manual lymphatic drainage therapy over a 3-4 week period.
|
home care
other → home care
shaky reasoning✓ Unanimous
Initial: other
Requery: home care — The intervention involves a Flexitouch Plus device that provides in-home manual lymphatic drainage therapy for approximately 1 hour daily, clearly indicating home-based treatment delivery.
|
home care
other → home care
shaky reasoning✓ Unanimous
Initial: other
Requery: home care — The intervention involves the use of in-home manual lymphatic drainage therapy devices (Flexitouch Plus) for treating lipo-lymphedema, indicating delivery at the patient's own home.
|
OK |
| feasibility |
feasibility RCT
feasibility RCT → feasibility RCT
shaky reasoning✓ Unanimous
Initial: feasibility RCT
Requery: feasibility RCT — The trial is a randomized interventional study with a small enrollment of 36 participants (n≤30 threshold for pilot/feasibility) and primary outcomes focused on clinical effectiveness measures (symptoms, quality of life, pain) without explicit pilot/feasibility labeling, but the small sample size suggests it is likely a feasibility or pilot study.
|
feasibility RCT
feasibility RCT → feasibility RCT
shaky reasoning✓ Unanimous
Initial: feasibility RCT
Requery: feasibility RCT — With only 36 participants enrolled, this appears to be a small-scale study designed to assess whether IPC treatment shows promise for symptom relief and quality of life improvements in lipo-lymphedema patients, rather than a fully powered efficacy trial.
|
feasibility RCT
fully powered RCT → feasibility RCT
shaky reasoning✓ Unanimous
Initial: fully powered RCT
Requery: feasibility RCT — The study has a relatively small sample size of 36 and focuses on evaluating symptoms and quality of life, which suggests it may be a preliminary or feasibility study.
|
OK |
| intervention_pharmacologic | no | no | no | OK |
| intervention_chemo_immuno_radio | no | no | no | OK |
| intervention_complementary | no | no | no | OK |
| intervention_device | yes | yes | yes | OK |
| intervention_psychological | no | no | no | OK |
| intervention_complex | no | no | no | OK |
| intervention_acp | no | no | no | OK |
| intervention_music | no | no | no | OK |
| intervention_screening | no | no | no | OK |
| intervention_palliative |
no
yes
shaky reasoning✓ Unanimous
Initial: yes
|
no
no → no
shaky reasoning✓ Unanimous
Initial: no
Requery: no — This study tests an intermittent pneumatic compression device for symptom management in women with lipo-lymphedema, not palliative care consultation or services as the intervention.
|
no
no → no
shaky reasoning✓ Unanimous
Initial: no
Requery: no — The study tests the effect of intermittent pneumatic compression on symptoms and quality of life, not palliative care as an intervention.
|
OK |
| intervention_education | no | no | no | OK |
| intervention_digital | no | no | no | OK |
| intervention_other | no | no | no | OK |
| outcome_symptom | yes | yes | yes | OK |
| outcome_qol | yes | yes | yes | OK |
| outcome_dignity | no | no | no | OK |
| outcome_cost | no | no | no | OK |
| outcome_other | yes | yes | yes | OK |
| pharmacologic_sub | N/A | N/A | N/A | OK |